MiR-181c-5p Mitigates Tumorigenesis in Cervical Squamous Cell Carcinoma via Targeting Glycogen Synthase Kinase 3β Interaction Protein (GSKIP) | Zendy

Niuniu Li | Zendy; Chun Cheng | Zendy; Tieyan Wang | Zendy

Open Access

<p>MiR-181c-5p Mitigates Tumorigenesis in Cervical Squamous Cell Carcinoma via Targeting Glycogen Synthase Kinase 3β Interaction Protein (GSKIP)</p>

Author(s) -

Niuniu Li,

Chun Cheng,

Tieyan Wang

Publication year - 2020

Publication title -

oncotargets and therapy

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 1.054

H-Index - 60

ISSN - 1178-6930

DOI - 10.2147/ott.s245254

Subject(s) - vimentin , carcinogenesis , cancer research , cd44 , cell growth , apoptosis , western blot , microbiology and biotechnology , cell , immunohistochemistry , biology , chemistry , cancer , medicine , gene , immunology , biochemistry , genetics

Cervical cancer (CC) is a highly prevalent cancer and one of the main causes of death among women worldwide. The miR-181 family has turned out to be associated with tumorigenesis in a variety of tumors by regulating the expression of tumor-related genes. However, the mechanisms and biological function of miR-181c-5p in cervical squamous cell carcinoma (SCC) have not been well elucidated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research